Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 292-301

  Welling, Mick M ^a   Paulusma Annema, Akke ^a   Balter, Henia S ^b   Pauwels, Ernest K J ^a   Nibbering, Peter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Antimicrobial peptides; Bacterial infection; Binding assay; Scintigraphy; Sterile inflammation; Technetium 99m labelling

Indexed keywords

DEFENSIN; LACTOFERRIN; LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TECHNETIUM 99M; UBIQUICIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BINDING AFFINITY; DRUG BINDING; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; INFLAMMATION; ISOTOPE LABELING; KLEBSIELLA PNEUMONIAE; LEUKOCYTE; MOUSE; NONHUMAN; QUANTITATIVE ASSAY; RABBIT; RADIOACTIVITY; SCINTIGRAPHY; STAPHYLOCOCCUS AUREUS;

EID: 0034106065     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050036     Document Type: Article

References (28)

1. Becker W. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med 1995; 22: 1195-1211.
2. Peters AM. The use of nuclear medicine in infections. Br J Radiol 1998; 71: 252-261.
3. Calame W, Welling MM, Feitsma RIJ, Ensing GJ, Pauwels EKJ. Improved detection of a staphylococcal infection by monomeric and protein A-purified polyclonal human immunoglobulin. Eur J Nucl Med 1993; 20: 490-494.
4. 99mTc-labelled monoclonal antibodies against TNF-α and interleukin-8. Nucl Med Biol 1997; 24: 649-655.
5. 99mTc-labelled human IgG: further improvement with enriched IgG subclass preparations. Nucl Med Commun 1997; 18: 1057-1064.
6. 99mTc-interleukin-2: a new radiopharmaceutical for in vivo detection of activated lymphocytes [abstract]. J Nucl Med 1994; 35: 807.
7. Vallabhajosula S. Technetium-99m-labeled chemotactic peptides: specific for imaging infection? J Nucl Med 1997; 38: 1322-1325.
8. 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996; 347: 233-235.
9. 99mtechnetium labeled antimicrobial human neutrophil peptide-1. J Nucl Med 1999; 40: 2073-2080.
10. Laterveer L, Lindley IJD, Heemskerk DPM, Camps JAJ, Pauwels EKJ, Willemze R, Fibbe WE. Rapid mobilization of haematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996; 87: 781-788.
11. Bryant RE, Mazza JA. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am J Med 1989; 87: 23-27.
12. Valtonen V, Karppinen L, Kariniemi AL. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. Scand J Infect Dis Suppl 1989; 60: 79-83.
13. Welling MM, Hiemstra PS, van den Barselaar MT, Paulusma-Annema A, Nibbering PH, Pauwels EKJ, Calame W. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest 1998; 102: 1583-1590.
14. Nibbering PH, Welling MM, van den Broek PJ, van Wyngaarden KE, Pauwels EKJ, Calame W. Radiolabelled antimicrobial peptides for imaging of infections. Nucl Med Commun 1998; 19: 1117-1121.
15. Hiemstra PS, Eisenhauer PB, Harwig SS, L., van den Barselaar MT, van Furth R, Lehrer RI. Antimicrobial proteins of murine macrophages. Infect Immun 1993; 61: 3038-3046.
16. van Berkel PHC, Geerts MEJ, van Veen HA, Kooiman PM, Pieper FR, de Boer HA, Nuijens JH. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide but differ in their susceptibilities towards tryptic proteolysis. Biochem J 1995; 312: 107-114.
17. Joiner KA, Ganz T, Albert J, Rotrosen D. The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes. J Cell Biol 1989; 109: 2771-2782.
18. 4 and stannous chloride. Nucl Med Biol 1993; 20: 825-833.
19. van Wetering S, Mannesse-Lazeroms SPG, van Sterkenburg MAJA, Daha MR, Dijkman JH, Hiemstra PS. Effects of defensins on IL-8 synthesis in airway epithelial cells. Am J Physiol 1997; 272: 888-896.
20. Hiemstra PS, van den Barselaar MT, Roest M, Nibbering PH, van Furth R. Ubiquicidin, a novel murine microbicidal protein in the cytosolic fraction of activated macrophages. J Leukocyte Biol 1999; 66: 423-428.
21. de Koster HS, Amons R, Benckhuijsen WE, Feijlbrief M, Schellekens GA, Drijfhout JW. The use of dedicated peptide libraries permits the discovery of high affinity binding peptides. J Immunol Meth 1995; 197: 179-188.
22. Bo A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens 1974; 4: 269-274.
23. Nibbering PH, Thio B, Zomerdijk PL, Bezemer AC, Beijersbergen RL, van Furth R. Effects of monomethylfumarate on human granulocytes. J Invest Dermatol 1993; 101: 37-42.
24. Hancock REW. Peptide antibiotics. Lancet 1997; 349: 418-422.
25. Panyutich A, Ganz T. Activated alpha 2-macroglobulin is a principal defensin-binding protein. Am J Respir Cell Mol Biol 1991; 5: 101-106.
26. Yomogida S, Nagaoka I, Yamashita T. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins. Comp Biochem Physiol B Biochem Mol Biol 1997; 116: 99-107.
27. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biophys Acta 1992; 1121: 130-136.
28. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol 1986; 60: 1068-1074.